IL90249A - 4-Hydroxytetrahydropyran-2-lobes, history of appropriate dihydrocarboxylic acids and salts, processes for their preparation and pharmaceutical preparations containing them - Google Patents
4-Hydroxytetrahydropyran-2-lobes, history of appropriate dihydrocarboxylic acids and salts, processes for their preparation and pharmaceutical preparations containing themInfo
- Publication number
- IL90249A IL90249A IL9024989A IL9024989A IL90249A IL 90249 A IL90249 A IL 90249A IL 9024989 A IL9024989 A IL 9024989A IL 9024989 A IL9024989 A IL 9024989A IL 90249 A IL90249 A IL 90249A
- Authority
- IL
- Israel
- Prior art keywords
- formula
- compound
- solution
- case
- carbon atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/01—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and halogen atoms, or nitro or nitroso groups bound to the same carbon skeleton
- C07C323/09—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and halogen atoms, or nitro or nitroso groups bound to the same carbon skeleton having sulfur atoms of thio groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3816388A DE3816388A1 (de) | 1988-05-13 | 1988-05-13 | Neue-6-phenoxymethyl-4-hydroxytetrahydropyran-2-one und 6-thiophenoxymethyl-4-hydroxytetrahydropyran-2-one, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und neue phenole sowie thiophenole |
| DE19883819999 DE3819999A1 (de) | 1988-06-11 | 1988-06-11 | Neue 6-phenoxymethyl-4-hydroxytetrahydropyran-2-one und 6-thiphenoxymethyl-4-hydroxytetrahydropyran-2 -one, sowie die entsprechenden dihydroxycarbonsaeurederivate, salze und ester, verfahren zur herstellung dieser verbindung, ihre verwendung als arzneimittel, pharmazeutische praeparate und neue phenole sowie thiophenole |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL90249A0 IL90249A0 (en) | 1989-12-15 |
| IL90249A true IL90249A (en) | 1994-01-25 |
Family
ID=25868078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL9024989A IL90249A (en) | 1988-05-13 | 1989-05-09 | 4-Hydroxytetrahydropyran-2-lobes, history of appropriate dihydrocarboxylic acids and salts, processes for their preparation and pharmaceutical preparations containing them |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0341681B1 (fi) |
| JP (1) | JP2833779B2 (fi) |
| KR (1) | KR900018062A (fi) |
| AU (1) | AU615060B2 (fi) |
| CA (1) | CA1338018C (fi) |
| DE (1) | DE58906520D1 (fi) |
| DK (1) | DK235389A (fi) |
| ES (1) | ES2061779T3 (fi) |
| FI (1) | FI96684C (fi) |
| HU (1) | HU206312B (fi) |
| IE (1) | IE63298B1 (fi) |
| IL (1) | IL90249A (fi) |
| NO (1) | NO172538C (fi) |
| NZ (1) | NZ229083A (fi) |
| PH (1) | PH26257A (fi) |
| PT (1) | PT90532B (fi) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3929913A1 (de) * | 1989-09-08 | 1991-04-04 | Hoechst Ag | 4-hydroxytetrahydropyran-2-one sowie die entsprechenden dihydroxycarbonsaeurederivate, salze und ester, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate sowie vorprodukte |
| EP0643054A3 (en) * | 1993-08-09 | 1995-05-03 | Fujirebio Kk | Process for the preparation of carbonic acid ester derivatives and intermediates. |
| US9045684B2 (en) * | 2012-07-30 | 2015-06-02 | Jnc Corporation | Liquid crystal composition, antioxidant and liquid crystal display device |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0216127B1 (de) * | 1985-08-29 | 1990-09-26 | Hoechst Aktiengesellschaft | 6-Phenoxymethyl-4-hydroxytetrahydropyran-2-one, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel, pharmazeutische Präparate und Zwischenprodukte |
| DE3530798A1 (de) * | 1985-08-29 | 1987-03-05 | Hoechst Ag | 6-phenoxymethyl-4-hydroxytetrahydropyran-2-one, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte |
| DE3632893A1 (de) * | 1986-09-27 | 1988-04-07 | Hoechst Ag | 4-(r)-hydroxy-6(s)-arylthiomethyl-tetrahydropyran-2-one, deren entsprechende sulfoxide und sulfone, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte |
| DE3929913A1 (de) * | 1989-09-08 | 1991-04-04 | Hoechst Ag | 4-hydroxytetrahydropyran-2-one sowie die entsprechenden dihydroxycarbonsaeurederivate, salze und ester, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate sowie vorprodukte |
-
1989
- 1989-05-09 IL IL9024989A patent/IL90249A/en not_active IP Right Cessation
- 1989-05-10 DE DE89108378T patent/DE58906520D1/de not_active Expired - Lifetime
- 1989-05-10 ES ES89108378T patent/ES2061779T3/es not_active Expired - Lifetime
- 1989-05-10 EP EP89108378A patent/EP0341681B1/de not_active Expired - Lifetime
- 1989-05-11 FI FI892291A patent/FI96684C/fi not_active IP Right Cessation
- 1989-05-11 PH PH38636A patent/PH26257A/en unknown
- 1989-05-11 PT PT90532A patent/PT90532B/pt not_active IP Right Cessation
- 1989-05-11 NZ NZ229083A patent/NZ229083A/en unknown
- 1989-05-12 CA CA000599613A patent/CA1338018C/en not_active Expired - Fee Related
- 1989-05-12 DK DK235389A patent/DK235389A/da not_active Application Discontinuation
- 1989-05-12 IE IE155489A patent/IE63298B1/en not_active IP Right Cessation
- 1989-05-12 NO NO891937A patent/NO172538C/no unknown
- 1989-05-12 HU HU892394A patent/HU206312B/hu not_active IP Right Cessation
- 1989-05-12 AU AU34715/89A patent/AU615060B2/en not_active Ceased
- 1989-05-12 JP JP1117649A patent/JP2833779B2/ja not_active Expired - Lifetime
- 1989-05-13 KR KR1019890006399A patent/KR900018062A/ko active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| FI892291A (fi) | 1989-11-14 |
| DK235389A (da) | 1989-11-14 |
| NO891937D0 (no) | 1989-05-12 |
| IE891554L (en) | 1989-11-13 |
| AU615060B2 (en) | 1991-09-19 |
| IL90249A0 (en) | 1989-12-15 |
| PT90532A (pt) | 1989-11-30 |
| FI96684C (fi) | 1996-08-12 |
| ES2061779T3 (es) | 1994-12-16 |
| EP0341681A3 (en) | 1990-05-16 |
| NO172538C (no) | 1993-08-04 |
| PH26257A (en) | 1992-04-01 |
| NZ229083A (en) | 1990-12-21 |
| IE63298B1 (en) | 1995-04-05 |
| DK235389D0 (da) | 1989-05-12 |
| NO891937L (no) | 1989-11-14 |
| PT90532B (pt) | 1994-11-30 |
| NO172538B (no) | 1993-04-26 |
| DE58906520D1 (de) | 1994-02-10 |
| HU206312B (en) | 1992-10-28 |
| JPH01319472A (ja) | 1989-12-25 |
| JP2833779B2 (ja) | 1998-12-09 |
| EP0341681A2 (de) | 1989-11-15 |
| HUT58309A (en) | 1992-02-28 |
| AU3471589A (en) | 1989-12-21 |
| CA1338018C (en) | 1996-01-30 |
| EP0341681B1 (de) | 1993-12-29 |
| FI96684B (fi) | 1996-04-30 |
| FI892291A0 (fi) | 1989-05-11 |
| KR900018062A (ko) | 1990-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5166171A (en) | 6-phenoxymethyl-4-hydroxytetrahydropyran-2-ones and 6-thiphenoxymethyl-4-hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters, and in treating hypercholesterolemia | |
| US4992429A (en) | Novel HMG-COA reductase inhibitors | |
| US4772626A (en) | Antihypercholesterolemic compounds | |
| JPH0665267A (ja) | リン含有ＨＭＧ−ＣｏＡリダクターゼ抑制剤および新規中間体 | |
| IE903262A1 (en) | 4-Hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters, process for their preparation, their use as pharmaceuticals, and pharmaceutical preparations and precursors | |
| AU2925989A (en) | Novel hmg-coa reductase inhibitors | |
| US5391569A (en) | New chromene compounds having a triene side chain | |
| IE50789B1 (en) | Substituted 6-phenethyl-and phenylethenyl-3,4,5,6-tetra-hydro-4-hydroxytetrahydropyran-2-ones in the 4-r trans stereoisomeric forms and the corresponding dihydroxy acids,process for preparing them and pharmaceutical compositions comprising them | |
| US5112864A (en) | PLA2 inhibitors as antiinflammatories | |
| IL90249A (en) | 4-Hydroxytetrahydropyran-2-lobes, history of appropriate dihydrocarboxylic acids and salts, processes for their preparation and pharmaceutical preparations containing them | |
| US4855324A (en) | Furyl, phenylene, and thienyl leukotriene B4 analogues | |
| HU195799B (en) | Process for producing pharmaceutical compositions containing 3-desmethyl-mevalonic acid derivatives and process for producing the active agents | |
| HUT62254A (en) | Process for producing 6-(hydronaphthyl-1-ethyl)-4-hydroxy-3,4,5,6-tetrahydro-2h-pyran-2-ones and the corresponding hydroxy acids | |
| US5177104A (en) | 6-α-hydroxy derivatives of mevinic acids | |
| EP0296580B1 (en) | Phenylene, furyl, and thienyl leukotriene b4 analogues | |
| US4855321A (en) | Antihypercholesterolemic compounds | |
| US4970234A (en) | Furyl, phenylene, and thienyl leukotriene B4 analogues | |
| IE904553A1 (en) | Ltb4 synthesis inhibitors | |
| US4970229A (en) | Furyl, phenylene, and thienyl leukotriene B4 analogues | |
| US4971997A (en) | Furyl, phenylene, and thienyl leukotriene B4 analogues | |
| DE3819999A1 (de) | Neue 6-phenoxymethyl-4-hydroxytetrahydropyran-2-one und 6-thiphenoxymethyl-4-hydroxytetrahydropyran-2 -one, sowie die entsprechenden dihydroxycarbonsaeurederivate, salze und ester, verfahren zur herstellung dieser verbindung, ihre verwendung als arzneimittel, pharmazeutische praeparate und neue phenole sowie thiophenole | |
| Djuric et al. | PLA 2 inhibitors as antiinflammatories | |
| EP0195097A1 (en) | Arachidonic acid analogues, processes for their preparation and their use in medicine | |
| DE3816388A1 (de) | Neue-6-phenoxymethyl-4-hydroxytetrahydropyran-2-one und 6-thiophenoxymethyl-4-hydroxytetrahydropyran-2-one, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und neue phenole sowie thiophenole | |
| CA2046584A1 (en) | Hmg-coa reductase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RH | Patent void |